Radboud University Medical Center
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
A Possible Therapeutic Role for Adenosine During Inflammation
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-08-08
- Last Posted Date
- 2009-10-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT00513110
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Trial to Reduce Falls Incidence Rate in Frail Elderly
- First Posted Date
- 2007-08-08
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 320
- Registration Number
- NCT00512655
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
π³π±Rijnstate Ziekenhuis, Arnhem, Netherlands
π³π±CWZ, Nijmegen, Netherlands
Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma
Completed
- Conditions
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2010-11-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT00509704
- Locations
- π³π±
UMC St Radboud, Nijmegen, Netherlands
Value of Urodynamics Prior to Stress Incontinence Surgery
Not Applicable
Terminated
- Conditions
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2009-10-07
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 290
- Registration Number
- NCT00509730
- Locations
- π³π±
UMC St.Radboud, Nijmegen, Gelderland, Netherlands
Phase 1 Study With Sorafenib and Sirolimus
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2009-09-18
- Lead Sponsor
- Radboud University Medical Center
- Registration Number
- NCT00509613
- Locations
- π³π±
UMC St Radboud, Nijmegen, Netherlands
Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2010-02-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT00509158
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Mass-Drug Administration to Reduce Malaria Transmission
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2008-08-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 6000
- Registration Number
- NCT00509015
- Locations
- πΉπΏ
Kilimanjaro Christian Medical Centre, Moshi, Tanzania
Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2008-07-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 70
- Registration Number
- NCT00509717
- Locations
- π³π±
UMC St Radboud, Scientific Institute for Quality of Healthcare, Nijmegen, NL, Netherlands
Does Statin Therapy Reduce Sympathoexcitation in Hypertension?
Not Applicable
Completed
- Conditions
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2008-09-30
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 13
- Registration Number
- NCT00497016
- Locations
- π³π±
Radboud University Medical Center Nijmegen, NIjmegen, Netherlands
Implementation Study of Dementia Guidelines in Primary Care
Not Applicable
- Conditions
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2007-04-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT00459784
- Locations
- π³π±
Geriatrie 925, Postbus 9101, Nijmegen, Netherlands
Β© Copyright 2024. All Rights Reserved by MedPath